The USC Norris Comprehensive Cancer Center is a cancer center owned and operated by the University of Southern California through its Keck School of Medicine.

During the past decade, USC Norris Comprehensive Cancer Center conducted 486 clinical trials. In the 10-year time frame, 486 clinical trials started and 286 clinical trials were completed, i.e. on average, 58.8% percent of trials that started reached the finish line to date. In the past 5 years, 191 clinical trials started and 142 clinical trials were completed. i.e. 74.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "USC Norris Comprehensive Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 202 trials, followed by "University of Southern California" with 199 trials sponsored, "SWOG Cancer Research Network" with 142 trials sponsored, "Radiation Therapy Oncology Group" with 59 trials sponsored and "Alliance for Clinical Trials in Oncology" with 59 trials sponsored. Other sponsors include 512 different institutions and companies that sponsored additional 224 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "USC Norris Comprehensive Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 528 trials as a collaborator, "NRG Oncology" with 41 trials as a collaborator, "SWOG Cancer Research Network" with 26 trials as a collaborator, "Cancer and Leukemia Group B" with 21 trials as a collaborator and "Eastern Cooperative Oncology Group" with 18 trials as a collaborator. Other collaborators include 296 different institutions and companies that were collaborators in the rest 162 trials.

According to Clinical.Site data, the most researched conditions in "USC Norris Comprehensive Cancer Center" are "Breast Cancer" (62 trials), "Lung Cancer" (41 trials), "Colorectal Cancer" (38 trials), "Lymphoma" (38 trials) and "Prostate Cancer" (38 trials). Many other conditions were trialed in "USC Norris Comprehensive Cancer Center" in a lesser frequency.

Most popular intervention types in "USC Norris Comprehensive Cancer Center" are "Drug" (912 trials), "Other" (330 trials), "Biological" (254 trials), "Procedure" (202 trials) and "Radiation" (167 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (160 trials), "Quality-of-Life Assessment" (71 trials), "radiation therapy" (65 trials), "cisplatin" (53 trials) and "Questionnaire Administration" (52 trials). Other intervention names were less common.

The vast majority of trials in "USC Norris Comprehensive Cancer Center" are 917 trials for "All" genders, 149 trials for "Female" genders and 85 trials for "Male" genders.

Currently, there are NaN active trials in "USC Norris Comprehensive Cancer Center". 2 are not yet recruiting, 168 are recruiting, 205 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 537 completed trials in USC Norris Comprehensive Cancer Center, 11 suspended trials, and 171 terminated clinical trials to date.

Out of the total trials that were conducted in USC Norris Comprehensive Cancer Center, 273 "Phase 1" clinical trials were conducted, 581 "Phase 2" clinical trials and 283 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 70 trials that are defined as “Not Applicable".